Health care resource utilization and costs for influenza-like illness among midwestern health plan members

Journal of Managed Care Pharmacy

Volumn 21, Issue 7, 2015, Pages 568-573

  Klepser, Donald G ^a   Corn, Carolyn E ^a   Schmidt, Michael ^b   Dering Anderson, Allison M ^c   Klepser, Michael E ^d  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b Blue Cross and Blue Shield of Nebraska   (United States)

^c Wal Mart Stores Inc   (United States)

^d FERRIS STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT;

ADULT; AMBULATORY CARE; ANTIVIRAL THERAPY; ARTICLE; COHORT ANALYSIS; COST BENEFIT ANALYSIS; CURRENT PROCEDURAL TERMINOLOGY; DIAGNOSTIC TEST; EMERGENCY CARE; FLU LIKE SYNDROME; HEALTH CARE COST; HEALTH CARE FACILITY; HEALTH CARE PLANNING; HEALTH CARE UTILIZATION; HEALTH INSURANCE; HOSPITALIZATION; HUMAN; ICD-9-CM; MAJOR CLINICAL STUDY; OUTPATIENT CARE; PATIENT CARE; PRESCRIPTION; RETROSPECTIVE STUDY; COST OF ILLNESS; ECONOMICS; INFLUENZA, HUMAN; PROCEDURES; STATISTICS AND NUMERICAL DATA; UNITED STATES;

ANTIVIRAL AGENTS; COHORT STUDIES; COST OF ILLNESS; DIAGNOSTIC TESTS, ROUTINE; HEALTH CARE COSTS; HOSPITALIZATION; HUMANS; INFLUENZA, HUMAN; INSURANCE, HEALTH; RETROSPECTIVE STUDIES; UNITED STATES;

EID: 84934757232     PISSN: 10834087     EISSN: None     Source Type: Journal    
DOI: 10.18553/jmcp.2015.21.7.568     Document Type: Article

References (9)

1. Thompson WW, Comanor L, Shay DK. Epidemiology of seasonal influenza:use of surveillance data and statistical models to estimate the burden of disease. J Infect Dis.2006;194(Suppl 2):S82-91. Available at: http://jid.oxfordjournals. org/content/194/Supplement_2/S82.long. Accessed May 23, 2015.
2. Molinari NA, Ortega-Sanchez IR, Messonnier ML, et al. The annual impact of seasonal influenza in the U.S.: measuring disease burden and costs. Vaccine. 2007;25(27):5086-96. Available at: http://www.sciencedirect. com/science/article/pii/S0264410X07003854. Accessed May 23, 2015.
3. Centers for Disease Control and Prevention. FluView: a weekly influenza surveillance report prepared by the Influenza Division. 2008-2009 Influenza Season Summary. January 5, 2008. Available at: http://www.cdc. gov/flu/weekly/weeklyarchives2008-2009/08-09summary.htm. Accessed May 23, 2015.
4. Jefferson T, Jones MA, Doshi P. et al. Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children. Cochrane Database Syst Rev. 2014;4:CD008965. Available at: http://onlinelibrary.wiley. com/doi/10.1002/14651858.CD008965.pub4/full. Accessed May 23, 2015.
5. Centers for Disease Control and Prevention. Influenza antiviral medications:summary for clinicians. March 21, 2014. Updated February 25, 2015. Available at: http://www.cdc.gov/flu/professionals/antivirals/summary-clinicians. htm. Accessed May 23, 2015.
6. Havers F, Thaker S, Clippard J. et al. Use of influenza antiviral agents by ambulatory care clinicians during the 2012-2013 influenza season. Clin Infect Dis. 2014;59(6):774-82.
7. Centers for Disease Control and Prevention. Rapid diagnostic testing for influenza: information for clinical laboratory directors. July 10, 2013. Updated November 5, 2014. Available at: http://www.cdc.gov/flu/professionals/ diagnosis/rapidlab.htm. Accessed May 23, 2015.
8. Klepser DG, Dering-Anderson A, Morse J, Klepser MK, et al. Innovative rural community pharmacy-based influenza management program. Presented at: 37th Annual National Rural Health Conference; Las Vegas, NV; April 23, 2014.
9. Klepser DG, Dering-Anderson A, Morse J, et al. Time and motion study of influenza diagnostic testing in a community pharmacy. Innov Pharm.2014;5(2):Article 159. Available at: http://www.pharmacy.umn.edu/innovations/ prod/groups/cop/@pub/@cop/@innov/documents/article/cop_article_478794.pdf. Accessed May 23, 2015.